Rectify Pharmaceutical Announces Publication of Trends in Molecular Medicine Review Article Highlighting the Therapeutic Potential of the ABC Transporter Superfamily December 13, 2022
Startup Spotlight: Rectify is hoping it can mend broken ABC transporters, starting in the liver November 13, 2021
Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund October 14, 2021
